THERAPEUTICS
Anti-protease combination therapy currently under development to reduce recurrent strokes, inflammation, and chronic pain in patients with Sickle Cell Disease and COVID-19.
DIAGNOSTICS
Novel diagnostic assays for babesiosis and cerebral malaria are currently under development. Our technology is guided by the phage display cDNA technology and rapid immunoassays.
REAGENTS & TOOLS
Antibodies, constructs, reagents, and protocols will be shared with the scientific community.